Diffusion-Weighted Magnetic Resonance Imaging of the Breast: Standardization of Image Acquisition and Interpretation
- PMID: 32901461
- PMCID: PMC7772373
- DOI: 10.3348/kjr.2020.0093
Diffusion-Weighted Magnetic Resonance Imaging of the Breast: Standardization of Image Acquisition and Interpretation
Abstract
Diffusion-weighted (DW) magnetic resonance imaging (MRI) is a rapid, unenhanced imaging technique that measures the motion of water molecules within tissues and provides information regarding the cell density and tissue microstructure. DW MRI has demonstrated the potential to improve the specificity of breast MRI, facilitate the evaluation of tumor response to neoadjuvant chemotherapy and can be employed in unenhanced MRI screening. However, standardization of the acquisition and interpretation of DW MRI is challenging. Recently, the European Society of Breast Radiology issued a consensus statement, which described the acquisition parameters and interpretation of DW MRI. The current article describes the basic principles, standardized acquisition protocols and interpretation guidelines, and the clinical applications of DW MRI in breast imaging.
Keywords: Cancer; Dense breast; Diffusion-weighted MRI; Standardization; Supplemental screening.
Copyright © 2021 The Korean Society of Radiology.
Conflict of interest statement
The authors have no potential conflicts of interest to disclose.
Figures






Similar articles
-
Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group.Eur Radiol. 2020 Mar;30(3):1436-1450. doi: 10.1007/s00330-019-06510-3. Epub 2019 Nov 30. Eur Radiol. 2020. PMID: 31786616 Free PMC article.
-
Diffusion-weighted MRI at 3.0 T for detection of occult disease in the contralateral breast in women with newly diagnosed breast cancer.Breast Cancer Res Treat. 2020 Jul;182(2):283-297. doi: 10.1007/s10549-020-05697-0. Epub 2020 May 23. Breast Cancer Res Treat. 2020. PMID: 32447596
-
Diffusion-weighted MRI for Unenhanced Breast Cancer Screening.Radiology. 2019 Dec;293(3):504-520. doi: 10.1148/radiol.2019182789. Epub 2019 Oct 8. Radiology. 2019. PMID: 31592734 Free PMC article. Review.
-
Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.Acta Radiol. 2014 Oct;55(8):909-16. doi: 10.1177/0284185113509094. Epub 2013 Nov 14. Acta Radiol. 2014. PMID: 24234236
-
Diffusion-weighted breast MRI: Clinical applications and emerging techniques.J Magn Reson Imaging. 2017 Feb;45(2):337-355. doi: 10.1002/jmri.25479. Epub 2016 Sep 30. J Magn Reson Imaging. 2017. PMID: 27690173 Free PMC article. Review.
Cited by
-
Understanding ADC variation by fat content effect using a dual-function MRI phantom.Eur Radiol Exp. 2024 Feb 13;8(1):19. doi: 10.1186/s41747-023-00414-0. Eur Radiol Exp. 2024. PMID: 38347188 Free PMC article.
-
Fat-signal suppression in breast diffusion-weighted imaging: the Good, the Bad, and the Ugly.Eur Radiol. 2025 Feb;35(2):733-741. doi: 10.1007/s00330-024-10973-4. Epub 2024 Aug 7. Eur Radiol. 2025. PMID: 39110181 Free PMC article.
-
Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea.J Breast Cancer. 2021 Apr;24(2):218-228. doi: 10.4048/jbc.2021.24.e19. J Breast Cancer. 2021. PMID: 33913277 Free PMC article.
-
Background Breast Parenchymal Signal During Menstrual Cycle on Diffusion-Weighted MRI: A Prospective Study in Healthy Premenopausal Women.Korean J Radiol. 2024 Jun;25(6):511-517. doi: 10.3348/kjr.2023.1189. Korean J Radiol. 2024. PMID: 38807333 Free PMC article.
-
Performance of high-resolution diffusion-weighted magnetic resonance imaging for detecting clinically occult early breast cancers: a multi-reader study.Breast Cancer Res Treat. 2025 Feb;210(1):71-86. doi: 10.1007/s10549-024-07537-x. Epub 2024 Nov 8. Breast Cancer Res Treat. 2025. PMID: 39511058
References
-
- Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427–437. - PubMed
-
- Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292:1317–1325. - PubMed
-
- Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469–8476. - PubMed
-
- Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) Lancet. 2005;365:1769–1778. - PubMed
-
- Lehman CD, Blume JD, Thickman D, Bluemke DA, Pisano E, Kuhl C, et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol. 2005;92:9–15. discussion 15–16. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources